These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7354124

  • 1. Suppression of prolactin and gonadotropin secretion in post-menopausal women by 2-hydroxyestrone.
    Schinfeld JS, Tulchinsky D, Schiff I, Fishman J.
    J Clin Endocrinol Metab; 1980 Feb; 50(2):408-10. PubMed ID: 7354124
    [Abstract] [Full Text] [Related]

  • 2. Absence of a suppressive effect of 2-hydroxyestrone on hyperprolactinemia in patients with prolactinomas before and after estradiol administration.
    Lamberts SW, Oosterom R.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):230-3. PubMed ID: 6401747
    [Abstract] [Full Text] [Related]

  • 3. Catechol estrogens and the control of gonadotropin and prolactin secretion in man.
    Merriam GR, Pfeiffer DG, Loriaux DL, Lipsett MB.
    J Steroid Biochem; 1983 Jul; 19(1B):619-25. PubMed ID: 6310245
    [Abstract] [Full Text] [Related]

  • 4. Does 2-hydroxyestrone suppress prolactin in women?
    Merriam GR, Kono S, Loriaux DL, Lipsett MB.
    J Clin Endocrinol Metab; 1982 Apr; 54(4):753-6. PubMed ID: 6801071
    [No Abstract] [Full Text] [Related]

  • 5. The effect of acutely administered 2-hydroxyestrone on the release of gonadotropins and prolactin before and after estrogen priming in hypogonadal women.
    Adashi EY, Rakoff J, Divers W, Fishman J, Yen SS.
    Life Sci; 1982 Apr; 25(24-25):2051-5. PubMed ID: 537468
    [No Abstract] [Full Text] [Related]

  • 6. Radioimmunoassay of 2-hydroxyestrone in plasma during the estrous cycle of the rat: interrelationships with estradiol, progesterone, and the gonadotropins.
    Cecchini DJ, Chattoraj SC, Fanous AS, Panda SK, Brennan TF, Edelin KC.
    Endocrinology; 1983 Mar; 112(3):1122-6. PubMed ID: 6401618
    [Abstract] [Full Text] [Related]

  • 7. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy.
    De Leo V, Petraglia F, Bruno MG, Lanzetta D, Inaudi P, D'Antona N.
    Gynecol Obstet Invest; 1989 Mar; 27(2):94-8. PubMed ID: 2499519
    [Abstract] [Full Text] [Related]

  • 8. Effects of chronic alcoholism on the pituitary-gonadal function of women during menopausal transition and in the post menopausal period.
    Hugues JN, Perret G, Adessi G, Coste T, Modigliani E.
    Biomedicine; 1978 Nov; 29(8):279-83. PubMed ID: 369630
    [Abstract] [Full Text] [Related]

  • 9. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME, Sheehan KL, Casper RF, Yen SS.
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [Abstract] [Full Text] [Related]

  • 10. Progesterone positive feedback on gonadotropin release in estrogen-primed postmenopausal women: central nervous system and pituitary as possible sites of action.
    Nicoletti I, Filipponi P, Fedeli L, Palumbo R, Santori P, Santeusanio F, Brunetti P.
    J Clin Endocrinol Metab; 1981 Jul; 53(1):135-8. PubMed ID: 6787064
    [Abstract] [Full Text] [Related]

  • 11. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer.
    Bird CE, Cook S, Owen S, Sterns EE, Clark AF.
    Oncology; 1981 Jul; 38(6):365-8. PubMed ID: 6795556
    [Abstract] [Full Text] [Related]

  • 12. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
    Helgason S.
    Acta Obstet Gynecol Scand Suppl; 1982 Jul; 107():1-29. PubMed ID: 6282033
    [Abstract] [Full Text] [Related]

  • 13. Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal women.
    Kolp LA, Pavlou SN, Urban RJ, Rivier JC, Vale WW, Veldhuis JD.
    J Clin Endocrinol Metab; 1992 Oct; 75(4):993-7. PubMed ID: 1400893
    [Abstract] [Full Text] [Related]

  • 14. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
    Lachelin GC, Yen SS.
    J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute effects of intravenous infusion of conjugated estrogen on serum levels of LH and FSH in post-menopausal and castrated women.
    Furuhashi N, Abe T, Suzuki M, Yamaya Y, Takahashi K, Hoshiai H, Wada Y.
    Tohoku J Exp Med; 1977 Apr; 121(4):315-9. PubMed ID: 194359
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hormone ontogeny in the ovine fetus: XIV. The effect of 17 beta-estradiol infusion on fetal plasma gonadotropins and prolactin and the maturation of sex steroid-dependent negative feedback.
    Gluckman PD, Marti-Henneberg C, Kaplan SL, Grumbach MM.
    Endocrinology; 1983 May; 112(5):1618-23. PubMed ID: 6403330
    [Abstract] [Full Text] [Related]

  • 19. Suppression of prolactin secretion in normal young women by 2-hydroxyestrone.
    Fishman J, Tulchinsky D.
    Science; 1980 Oct 03; 210(4465):73-4. PubMed ID: 7414322
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F.
    J Clin Invest; 1976 May 03; 57(5):1320-9. PubMed ID: 770505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.